Recent Events - AVIC Shenyang Aircraft Corporation appointed Zuo Linxuan as the new general manager, previously serving as deputy general manager and chief engineer, indicating an optimization of the company's governance structure [1] - The company implemented a cash dividend on February 11, 2026, as part of the pre-Spring Festival dividend wave in the A-share market, reflecting the regulatory emphasis on investor returns [1] - On February 12, 2026, the U.S. conducted a "Red Flag" exercise simulating threats from China's J-20 and J-35 fighter jets, highlighting international attention on China's stealth aircraft technology, which may indirectly affect the sentiment in the military industry sector [1] Stock Performance - The stock price has shown volatility, dropping 2.00% to 54.82 yuan on February 11, with a trading volume of 775 million yuan and a net outflow of 130 million yuan from main funds; it rebounded to 55.66 yuan on February 13, with a single-day increase of 1.46% and a trading volume of 1.394 billion yuan, although main funds still experienced a net outflow of 5.9186 million yuan [1] - Over the past five days, the cumulative increase was 1.27%, with a fluctuation of 3.37%; technical analysis indicates the stock price is near the lower Bollinger Band, with a 20-day resistance level at 61.09 yuan and a support level at 52.06 yuan [1] Institutional Perspectives - Institutions maintain an optimistic outlook for the medium to long term, with a comprehensive target price of 68.43 yuan, indicating a potential upside of 22.94% from the latest price [3] - Profit forecasts suggest a 4.16% year-on-year increase in net profit for 2025, with growth accelerating to 16.29% in 2026, primarily driven by military trade expansion and expectations for J-35 mass production [3] - Recent institutional ratings are predominantly "buy" or "hold," but attention is required on delivery schedules and risks associated with military product pricing mechanism reforms [3]

Market Overview - The market experienced fluctuations in the early session, with all three major indices declining collectively, and the ChiNext Index leading the drop. The CSI A500 Index fell by 0.83% [1] - The military industry sector showed the highest gains, while the semiconductor sector was active, and the paper-making concept strengthened repeatedly. Conversely, the port and shipping concept saw a collective decline [1] ETF Performance - As of the morning close, the ETFs tracking the CSI A500 Index dropped nearly 1%. Notably, 11 CSI A500-related ETFs had transaction volumes exceeding 100 million yuan, with 2 surpassing 7.2 billion yuan. The A500 ETF Fund and A500 ETF Huatai-PB had transaction volumes of 9.776 billion yuan and 7.27 billion yuan, respectively [1] - Specific ETF performance included: - A500 ETF Fund: Current price 1.235, down 0.80% - A500 ETF Huatai-PB: Current price 1.313, down 0.76% - CSI A500 ETF: Current price 1.243, down 0.88% - A500 ETF Southern: Current price 1.292, down 0.84% - A500 ETF E Fund: Current price 1.266, down 0.78% [2] Market Sentiment - Analysts indicated that there is currently no clear main theme in the market, with sectors rotating based on events or news catalysts, lacking sustainability. The recommendation is to remain observant and await increased capital flow post-holiday [1]

Core Viewpoint - The recent report from Dongfang Securities highlights that the recent adjustments in the commercial aerospace sector do not alter the long-term industry trends, with the C919 large aircraft's international certification process accelerating, and the military industry sector showing a resonance of internal and external demand, emphasizing its investment value [1][7]. Group 1: C919 Aircraft Development - The C919 has received flight test recognition from the European Union Aviation Safety Agency (EASA), which is crucial for its entry into European and international markets [2][8]. - EASA's certification is considered a key pass for the C919, which has already completed passenger transport for millions domestically, validating its market potential [2][8]. Group 2: Commercial Aerospace and Technological Advancements - The China Aerospace Science and Technology Corporation's 2026 annual meeting emphasized the need to advance major projects like manned moon landings and deep space exploration, while also focusing on breakthroughs in reusable rocket technology [3][9]. - Recent technological breakthroughs in the commercial aerospace sector include successful static fire tests and suborbital flight tests, indicating a rapid development trajectory for the industry [3][9]. - The competition for near-Earth orbital resources is intensifying, with low Earth orbit satellite constellations becoming a new arena for major powers, prompting China to accelerate the large-scale and systematic construction of these constellations [3][9]. Group 3: Military Industry Investment Opportunities - Dongfang Securities indicates that the "14th Five-Year Plan" has commenced, with new equipment construction plans soon to be clarified, highlighting the military sector's investment value [4][10]. - In the short term, attention should be given to areas related to unmanned and counter-unmanned equipment, deep-sea technology, and operational information technology following the implementation of the "14th Five-Year Plan" [4][10]. - In the long term, military enterprises have significant growth potential in civil aviation and commercial aerospace, with the acceleration of high-end Chinese equipment exports likely to expand the military trade market [4][10]. - Investment targets include various fields such as commercial aerospace, aerospace engines and turbines, new domains, military electronics, and military trade/main equipment [4][10].

Market Strategy - The market is experiencing a volume contraction rebound, and a short-term wait for a warming signal is necessary [5][10] - The A-share market has seen significant volatility due to tightening overseas liquidity, geopolitical risks, and a rebalancing of market styles [10] - The military industry and AI application sectors are highlighted as areas of potential growth, with military stocks showing strength due to recent government plans for modernization [9][10] Company Tracking - Zhongchumai (688267) plans to increase its holdings by no less than 42 million yuan, reflecting confidence in the company's long-term investment value [26] - Shennagong (600810.SH) is establishing a nylon 66 high-performance fabric project in Ningdong, with a total investment of 169 million yuan, expected to meet growing domestic demand [28] - Hengrui Medicine (600276.SH) has received approval for the launch of paricalcitol soft capsules, marking a significant milestone as the first domestic generic version [30] - Dajin Heavy Industry (002487.SZ) has signed an exclusive supply contract for a European offshore wind farm project, valued at approximately 1.339 billion yuan, which is expected to contribute significantly to its revenue [31] - Dajin Heavy Industry is also investing in a 950,000 kW onshore wind power project in Hebei, with a total investment not exceeding 4.38 billion yuan [35] Economic Dynamics - The National Energy Administration reported a 17.3% year-on-year increase in total installed power generation capacity, reaching 3.75 billion kW by the end of October [25] - The recent Hunan General Aviation Expo resulted in project signings exceeding 4.4 billion yuan, indicating strong investment interest in the low-altitude economy [39]

Market Overview - The market is experiencing weakness with the Shanghai Composite Index opening lower and declining further, while the Shenzhen Component and ChiNext indices saw a slight reduction in their losses towards the end of the trading session [1] - There is rapid rotation of market hotspots, with the lithium battery industry chain experiencing a collective surge, the Fujian sector maintaining strength, and AI application concepts gaining momentum [1] ETF Performance - Rare metals ETFs showed significant gains, with the following performances: - 159608.SZ Rare Metals ETF increased by 3.68% - 562800.SH Rare Metals ETF rose by 3.66% - 561800.SH Rare Metals ETF Fund up by 3.22% [2] Industry Insights - Analysts suggest that the limited reserves of strategic minor metals, along with high extraction difficulties and insufficient supply elasticity, are leading to intensified supply-demand conflicts due to rapid growth in downstream demand from sectors like new energy, semiconductors, and military industry [3] - The ongoing scarcity of resources, upgrading demand structure, and policy adjustments are expected to drive rare metal prices upward, benefiting companies with resource reserves, technological barriers, and compliant export channels [3] Declining Sectors - The innovative pharmaceutical sector and gold-related ETFs have seen declines, with the following notable drops: - 589720.SH Innovative Drug ETF down by 2.7% - 159562.SZ Gold Stock ETF decreased by 2.57% [4][5] Biotechnology Developments - The biotechnology sector in China is witnessing positive developments, with multiple innovative drug companies having 35 studies selected for oral presentations at the ESMO 2025 conference, setting a new record [5] - Significant collaborations are emerging, such as the partnership between Innovent Biologics and Takeda, valued at up to $11.4 billion, reflecting global market recognition of the value of Chinese innovative drugs [5]

Group 1 - A-shares experienced fluctuations with the Shenzhen Component Index turning positive before retreating again, with a half-day trading volume of 1.27 trillion, an increase of 32.9 billion compared to the previous trading day [1] - Over 2900 stocks in the market declined, indicating a broad market downturn despite some sector performances [1] Group 2 - The Fujian sector saw a resurgence, with stocks like Xiamen Construction and Pingtan Development hitting the daily limit, alongside a strong performance in AI application concepts with multiple stocks such as 360 also reaching the limit [5] - The military industry sector continued its strong performance, with Aerospace Development achieving two consecutive limit-ups, while the lithium mining concept remained active with Dazhong Mining hitting three consecutive limit-ups [5] - In contrast, the pharmaceutical sector showed divergence, with stocks like Jimin Health and Yaoyigou experiencing declines, while sectors such as energy metals, military equipment, and AI applications led in gains, and precious metals and pharmaceuticals faced the largest declines [5] - At market close, the Shanghai Composite Index fell by 0.43%, the Shenzhen Component Index decreased by 0.35%, and the ChiNext Index dropped by 0.8% [5]

Group 1 - The core viewpoint of the news highlights the increasing importance of commercial aerospace in China's strategic development, with a focus on technological breakthroughs and capital acceleration in the industry [1][2]. - The Fourth Plenary Session of the Central Committee added the term "aerospace power," indicating a renewed emphasis on commercial aerospace following the mention of "new growth engines" [1]. - The 14th Five-Year Plan suggests accelerating the development of strategic emerging industries, including new energy, new materials, aerospace, and low-altitude economy, which is expected to create several trillion-yuan markets [1]. Group 2 - The commercial aerospace sector is entering a high-density launch period, with significant advancements in satellite deployment and launch frequency, closely approaching the launch density of SpaceX's Starlink system [2]. - The recent successful launch of the Tianlong-3 large liquid carrier rocket, achieving the simultaneous separation of 36 satellites, marks a significant milestone in China's commercial aerospace capabilities [2]. - The procurement announcement from Yuanxin in July indicates plans for multiple rocket launches, with a total of 94 satellites to be deployed by 2026, further accelerating the launch schedule [2]. Group 3 - According to Xinda Securities, the military industry sector is becoming more attractive in terms of valuation, with recommendations to overweight the military industry, focusing on new combat systems, unmanned equipment, satellite internet, and commercial aerospace [3]. - The National Defense ETF closely tracks the CSI National Defense Index, which includes listed companies under major military groups and those providing equipment to the armed forces, reflecting the overall performance of the defense industry [3]. - The management and custody fees for the National Defense ETF are the lowest among similar ETFs, at only 0.40% [3]. Group 4 - As of September 30, 2025, the top ten weighted stocks in the CSI National Defense Index include companies like AVIC Shenyang Aircraft (600760) and Aero Engine Corporation of China (600893), collectively accounting for 45.45% of the index [6].

Core Viewpoint - The AI Fund, Agricultural Bank's Dividend Selection Mixed A (021455), reported a profit of 1.4429 million yuan for the first half of 2025, with a net value growth rate of 7.74% [3] Group 1: Fund Performance - As of September 3, 2025, the fund's unit net value was 1.207 yuan, with a recent three-month growth rate of 14.00%, a six-month growth rate of 21.99%, and a one-year growth rate of 20.70% [5][3] - The fund's scale reached 8.9124 million yuan by the end of the first half of 2025 [3][36] Group 2: Investment Strategy - The fund manager highlighted preferred investment directions including defensive dividend assets such as banks, thermal power, hydropower, and highways; consumer sectors like hotels and scenic spots during peak travel seasons; agricultural chemicals; and military sectors influenced by geopolitical events [3] Group 3: Valuation Metrics - As of June 30, 2025, the fund's weighted average price-to-earnings (P/E) ratio was approximately 15.8 times, with a weighted price-to-book (P/B) ratio of about 1.77 times, and a weighted price-to-sales (P/S) ratio of around 1.6 times, all higher than the respective averages of comparable funds [10] Group 4: Growth Metrics - For the first half of 2025, the weighted revenue growth rate of the stocks held by the fund was 0.06%, and the weighted net profit growth rate was 0.01% [20] Group 5: Fund Composition and Shareholder Structure - As of June 30, 2025, the fund had 596 holders, with individual investors holding 98.30% of the shares, while management and institutional investors held 2.47% and 1.70%, respectively [39] - The fund's top ten holdings included companies like Changjiang Electric Power and Luxshare Precision [44]

Group 1 - The A-share market showed mixed performance on September 2, with sectors like power batteries and solid-state batteries rising, while the military industry sector experienced a pullback [1] - The Aerospace ETF (159227) saw a decline of 1.66% with a trading volume of 21.64 million yuan, marking it as the largest in its category. It has experienced a net inflow of over 200 million yuan in the past three days, reaching a new high of 1.217 billion yuan in total assets [1] - The aerospace sector is increasingly important in modern warfare, with high technical barriers and significant value in the military industrial chain. China's military enterprises are showing advantages in drones, fighter jets, and missiles, making the aerospace sector a core beneficiary [1] Group 2 - The National Aerospace Index yielded a return of 68.42% from August 29, 2024, to August 29, 2025, outperforming other indices such as the CSI National Defense Index (57.03%) and the CSI Military Industry Index (59.85%) [2] - Shanxi Securities indicated that 2025 will be a pivotal year, with demand improving as delayed orders from the 14th Five-Year Plan are gradually released. The military industry sector is expected to rebound in the second half of 2025 as the 15th Five-Year Plan is initiated and the 100-year military goal approaches [2]

Macro - In the first half of the year, listed companies achieved operating income of 35.01 trillion yuan, a year-on-year increase of 0.16%; net profit reached 3 trillion yuan, with a year-on-year growth of 2.54%, an increase of 4.76 percentage points compared to the previous year's full-year growth [3][4] - In August, the manufacturing PMI was 49.4%, up 0.1 percentage points month-on-month; the non-manufacturing business activity index was 50.3%, up 0.2 percentage points month-on-month; the composite PMI output index was 50.5%, up 0.3 percentage points month-on-month [3] - Several banks indicated that they continued to support the stabilization of the real estate market in the first half of the year by increasing mortgage loan issuance, with the second-hand housing loan issuance increasing by over 20% year-on-year [4] Convertible Bonds - In August, the convertible bond market continued to be active, with the convertible bond index rising by 4.32%, underperforming the overall market index which rose by 10.74% [6] - The high-priced convertible bond index outperformed low-priced and mid-priced indices, with an increase of 8.92% in August, indicating stronger performance in a rising equity market [6][9] - The dual-low strategy underperformed in a strong market, with only a 2.48% increase in August, while the high-priced low-premium strategy rose by 7.07% [9] Traditional Chinese Medicine Industry - Shouxiangu reported a 16.51% decrease in operating income to 300 million yuan in the first half of 2025, with a net profit decline of 33.99% to 65.56 million yuan [14] - The company expects performance to improve in the third quarter, as July saw a return to positive growth in revenue [15] - The company is expanding its online channels, with internet sales increasing by 15.14% year-on-year, while traditional sales channels are being enhanced through strategic partnerships [16] Innovative Drug Industry - Sanofi's half-year report showed a revenue of 4.36 billion yuan, a slight decrease of 0.8%, while net profit increased by 24.6% to 1.36 billion yuan [20] - The company is focusing on innovative therapies, with several products in clinical trials, including SSGJ-707, which has potential for significant market value [21] - Existing products are performing steadily, with a notable increase in sales in the hair loss segment, while other segments are experiencing slight fluctuations [22] Medical Equipment - Ruimait's half-year performance was strong, with a revenue of 544 million yuan, a year-on-year increase of 42.30%, and a net profit of 131 million yuan, also up 42.19% [25] - The company has improved its expense ratios significantly, with a sales expense ratio of 10.43%, down 2.24 percentage points year-on-year [26] - The rebranding to "Ruimait" is expected to enhance brand value and market penetration, aligning the company's identity with its core products [28]